drugset / Trial / NCT02881866

Specificity of Dyspnoea Relief With Inhaled Furosemide

NCT02881866 ↗

Phase 1 Completed 16 enrolled Oxford Brookes University
RandomizedCrossoverQuadruple-blindBasic science

Summary

This study evaluates the effect of inhaled furosemide on different types of breathlessness relief in healthy volunteers. Each volunteer inhaled mists of either furosemide or a control substance on 3 occasions per day on 2 separate days. On one day they performed one breathlessness test which creates an 'urge to breathe' known as air hunger (AH) and the other day they performed a breathlessness test which increases the sense of work/effort (WE) of breathing. The study is double blinded so neither the volunteer or the research knows which mist is being inhaled.

Timeline

Start
2015-10
Primary completion
2016-03
Completion
2016-03

Outcome

Mixed primary results

paper Primary outcome was ratings of air hunger or work/effort every 15 s on a visual analogue scale. PMID 30236110 ↗

paper Inhaled furosemide relative to inhaled saline significantly improved visual analogues scale ratings of air hunger (Least Squares Mean ± SE - 9.7 ± 2%; p = 0.0015) PMID 30236110 ↗

paper but not work/effort (+ 1.6 ± 2%; p = 0.903). PMID 30236110 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified 40 mg Inhaled

Indications

No indication recorded.